Targeting Macrophages: Therapeutic Approaches in Diabetic Kidney Disease

Int J Mol Sci. 2024 Apr 15;25(8):4350. doi: 10.3390/ijms25084350.

Abstract

Diabetes is not solely a metabolic disorder but also involves inflammatory processes. The immune response it incites is a primary contributor to damage in target organs. Research indicates that during the initial phases of diabetic nephropathy, macrophages infiltrate the kidneys alongside lymphocytes, initiating a cascade of inflammatory reactions. The interplay between macrophages and other renal cells is pivotal in the advancement of kidney disease within a hyperglycemic milieu. While M1 macrophages react to the inflammatory stimuli induced by elevated glucose levels early in the disease progression, their subsequent transition to M2 macrophages, which possess anti-inflammatory and tissue repair properties, also contributes to fibrosis in the later stages of nephropathy by transforming into myofibroblasts. Comprehending the diverse functions of macrophages in diabetic kidney disease and regulating their activity could offer therapeutic benefits for managing this condition.

Keywords: diabetic kidney disease; macrophage; polarization.

Publication types

  • Review

MeSH terms

  • Animals
  • Diabetic Nephropathies* / drug therapy
  • Diabetic Nephropathies* / metabolism
  • Diabetic Nephropathies* / pathology
  • Fibrosis
  • Humans
  • Macrophages* / immunology
  • Macrophages* / metabolism